Kelderman Kim
SEC CIK 1739054 · EDGAR
BoughtSold
Most active insiders at CNMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garner Todd W | EVP, CFO | — | $150.5K |
| 2 | Glaze Richard | CIO | — | $10.6K |
| 3 | Foust Hollie K | GC, Corp Sec | — | — |
| 4 | Lalomia Brent | Executive VP RA, QA | — | — |
| 5 | Council LaVerne H | Dir | — | — |
| 6 | Schwarzentraub Barbara J | Dir | — | — |
| 7 | Kaye Mark | Dir | — | — |
| 8 | Kelderman Kim | Dir | — | — |
| 9 | Farkas Charles | Dir | — | — |
| 10 | Bronson David M. | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-10 15:13 | 2026-09-08 | CNMD | CONMED Corp | Kelderman Kim | Dir | M - OptEx | $0.00 | +500 | 500 | New | $0 |
| D | 2026-08-18 17:14 | 2026-08-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +21.5K | 93.6K | +30% | $0 |
| D | 2026-08-18 17:14 | 2026-08-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $72.40 | -10.8K | 82.8K | -12% | -$783.4K |
| D | 2026-07-30 16:11 | 2026-07-28 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $47.60 | +35.0K | 100.8K | +53% | +$1.67M |
| D | 2026-07-30 16:11 | 2026-07-28 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $72.07 | -28.7K | 72.1K | -28% | -$2.07M |
| D | 2026-05-07 17:22 | 2026-05-05 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $47.60 | +26.7K | 89.8K | +42% | +$1.27M |
| D | 2026-05-07 17:22 | 2026-05-05 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $56.68 | -24.0K | 65.8K | -27% | -$1.36M |
| D | 2026-04-24 18:06 | 2026-04-22 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +11.3K | 64.4K | +21% | $0 |
| D | 2026-04-24 18:06 | 2026-04-22 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $58.58 | -1,363 | 63.1K | -2% | -$79.8K |
| D | 2026-04-16 16:19 | 2026-04-14 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +36.5K | 85.2K | +75% | $0 |
| D | 2026-04-16 16:19 | 2026-04-14 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $58.66 | -32.1K | 53.1K | -38% | -$1.88M |
| 2025-11-05 | 2025-11-03 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $62.57 | -2,303 | 48.7K | -5% | -$144.1K | |
| D | 2025-08-19 | 2025-08-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $53.60 | -4,305 | 51.0K | -8% | -$230.7K |
| D | 2025-08-19 | 2025-08-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +8,543 | 55.3K | +18% | $0 |
| D | 2025-07-24 | 2025-07-22 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $53.12 | -43.6K | 46.7K | -48% | -$2.32M |
| D | 2025-07-24 | 2025-07-22 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $44.33 | +48.2K | 90.4K | +114% | +$2.14M |
| D | 2025-07-17 | 2025-07-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $51.42 | -32.9K | 42.2K | -44% | -$1.69M |
| D | 2025-07-17 | 2025-07-15 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $44.33 | +36.1K | 75.1K | +93% | +$1.60M |
| DM | 2025-01-29 | 2025-01-27 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | S - Sale+OE | $77.28 | -13.4K | 39.0K | -26% | -$1.03M |
| D | 2025-01-29 | 2025-01-27 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $37.70 | +13.4K | 52.4K | +34% | +$504.9K |
| 2024-11-05 | 2024-11-01 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $75.31 | -2,430 | 39.0K | -6% | -$183.0K | |
| D | 2024-09-03 | 2024-08-29 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $66.97 | +1,492 | 41.4K | +4% | +$99.9K |
| D | 2024-08-02 | 2024-07-31 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | F - Tax | $81.97 | -9,479 | 39.9K | -19% | -$777.0K |
| D | 2024-08-02 | 2024-07-31 | TECH | Bio-Techne | Kelderman Kim | CEO, Dir | M - OptEx | $37.70 | +14.0K | 49.4K | +40% | +$527.8K |
| D | 2023-11-03 | 2023-11-01 | TECH | Bio-Techne | Kelderman Kim | COO | A - Grant | $0.00 | +14.2K | 35.4K | +67% | $0 |
| D | 2023-08-28 | 2023-08-24 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $47.60 | +2,100 | 21.2K | +11% | +$100.0K |
| D | 2023-08-08 | 2023-08-05 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +8,060 | 23.3K | +53% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $82.17 | -4,139 | 19.1K | -18% | -$340.1K |
| D | 2022-08-25 | 2022-08-23 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +663 | 3,801 | +21% | +$100.0K |
| D | 2022-08-09 | 2022-08-07 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +2,363 | 4,352 | +119% | $0 |
| D | 2022-08-09 | 2022-08-07 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $382.97 | -1,214 | 3,138 | -28% | -$464.9K |
| D | 2022-02-10 | 2022-02-08 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +1,989 | 1,989 | New | +$299.9K |
| DM | 2021-11-23 | 2021-11-19 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | S - Sale+OE | $505.38 | -500 | 400 | -56% | -$252.7K |
| D | 2021-11-23 | 2021-11-19 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $150.78 | +500 | 500 | New | +$75.4K |
| 2021-09-24 | 2021-09-22 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | S - Sale | $529.04 | -822 | 0 | -100% | -$434.9K | |
| D | 2021-08-10 | 2021-08-08 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $481.82 | -869 | 822 | -51% | -$418.7K |
| D | 2021-08-10 | 2021-08-08 | TECH | Bio-Techne | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +1,691 | 1,691 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations